What Do Analysts Say About Adaptimmune Therapeutics Plc ADR (ADAP)?
Adaptimmune Therapeutics Plc ADR (ADAP) saw downtrend of -4.17% in the recent trading with $0.99 being its most recent. The current price level -51.85% lower than the highest price of $2.05 marked by the stock while trading over the past 52-weeks, whereas it is 135.00% higher than the lowest price of $0.42 the company dropped […]
What Do Analysts Say About Adaptimmune Therapeutics Plc ADR (ADAP)?
Adaptimmune Therapeutics Plc ADR (ADAP) saw downtrend of -7.30% in the recent trading with $1.27 being its most recent. The current price level -38.05% lower than the highest price of $2.05 marked by the stock while trading over the past 52-weeks, whereas it is 202.38% higher than the lowest price of $0.42 the company dropped […]
Adaptimmune Therapeutics Plc ADR (ADAP): The stock short term indicators are indicating Buy today
Adaptimmune Therapeutics Plc ADR (ADAP) saw downtrend of -1.43% in the recent trading with $1.38 being its most recent. The current price level -32.68% lower than the highest price of $2.05 marked by the stock while trading over the past 52-weeks, whereas it is 228.57% higher than the lowest price of $0.42 the company dropped […]
Adaptimmune Therapeutics Plc ADR (ADAP): The stock short term indicators tell us to Buy today
Adaptimmune Therapeutics Plc ADR (ADAP) saw downtrend of 0.00% in the recent trading with $1.44 being its most recent. The current price level -29.76% lower than the highest price of $2.05 marked by the stock while trading over the past 52-weeks, whereas it is 242.86% higher than the lowest price of $0.42 the company dropped […]
Adaptimmune Therapeutics Plc ADR (ADAP): The stock long term indicators say Buy today
Adaptimmune Therapeutics Plc ADR (ADAP) saw an uptrend of 7.46% in the recent trading with $1.44 being its most recent. The current price level -29.76% lower than the highest price of $2.05 marked by the stock while trading over the past 52-weeks, whereas it is 242.86% higher than the lowest price of $0.42 the company […]
Adaptimmune Therapeutics Plc ADR (ADAP): The stock’s intermediate-term indicators point to Sell today
Adaptimmune Therapeutics Plc ADR (ADAP) saw an uptrend of 2.13% in the recent trading with $0.73 being its most recent. The current price level -63.19% lower than the highest price of $1.97 marked by the stock while trading over the past 52-weeks, whereas it is 72.64% higher than the lowest price of $0.42 the company […]
